Joseph Ricotta, MD
Vascular Surgery · Delray Beach, FLNPI 1407824097
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.0%), consulting fees and grants — rather than concentrated in one kind of arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 23.7%. 2025 is the largest year on record at $50,922, 5.5 times the $9,178 reported in 2019. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 713 payments — averaging $218.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$37K
- Philips North America LLC$36K
- Boston Scientific$35K
- Silk Road Medical, Inc.$34K
- Endologix LLC$3K
- W. L. Gore & Associates, Inc.$2K
- plus $10K from 46 others
Across 90 payments — averaging $2095.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$61K
- Bard Peripheral Vascular, Inc.$36K
- EKOS Corporation$18K
- Boston Scientific$18K
- Shape Memory Medical Inc.$14K
- Penumbra, Inc.$13K
- plus $29K from 4 others
What the payments were for
- Consulting fees$42,99028%
- Speaking & faculty fees$62,32040%
- Grants$25,00016%
- Travel & lodging$1,5671%
- Food & beverage$20,76313%
- Education$2020%
- Gifts$2,9952%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$67,424
- ENROUTE Transcarotid Stent$32,841
- (6554) Periph Vasc Undiv$26,325
- ENDURANT IIS$10,112
- VenaSeal$6,800
- (6554) Peripheral Vascular Undivided$4,875
- ENHANCE Transcarotid Peripheral Access Kit$3,986
- ENROUTE .014 Guidewire$3,855
- ClosureFast$3,200
- IGT Devices Und$2,995
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$2,150
- Alto Abdominal Stent Graft System$2,076
- ESPRIT$764
- Ovation$371
- Indigo System$257
- GENERAL VASCULAR INTERVENTION$237
- Diamondback Peripheral$230
- Indigo$214
- ENDOCROSS Device$169
- Torus Stent Graft System$169
How this compares
$155,837 in reported general payments places this provider in the 95th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 103 | $51,846 |
| EliquisApixaban | 23 | $16,327 |
| XareltoRivaroxaban | 12 | $7,716 |
| ClopidogrelClopidogrel Bisulfate | 307 | $2,754 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 433 | $1,782 |
| Cephalexin | 155 | $222 |
| Tramadol Hcl | 53 | $99 |
| Doxycycline Hyclate | 36 | $58 |
| Diazepam | 15 | $9 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $16,32723 claims |
| Johnson & JohnsonXarelto | $147 | $7,71612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Delray Beach
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Manuel Perez IzquierdoOrlando$302K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
- Joseph WasselleMelbourne$161K
- Murray ShamesTampa$144K
- K Dean ArnaoutakisTampa$115K
- Lina Vargas AbelloWindermere$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.